The synergistic effect between LAG-3 and PD-1 has been described in murine melanoma, colorectal adenocarcinoma, and fibrosarcoma models where the dual blockade of both PD-1 and LAG-3 resulted in tumor eradication and prolonged survival in mice [91]. Here, PDCD1 is linked to melanoma.